Rhenman & Partners Asset Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-370,000
| Closed | -$2.01M | – | 96 |
|
|
2022
Q4 | $2.01M | Hold |
370,000
| – | – | 0.21% | 82 |
|
|
2022
Q3 | $3.94M | Buy |
370,000
+53,863
| +17% | +$574K | 0.41% | 66 |
|
|
2022
Q2 | $1.56M | Hold |
316,137
| – | – | 0.18% | 82 |
|
|
2022
Q1 | $2.4M | Sell |
316,137
-8,863
| -3% | -$67.4K | 0.24% | 85 |
|
|
2021
Q4 | $3.4M | Hold |
325,000
| – | – | 0.23% | 82 |
|
|
2021
Q3 | $4.36M | Hold |
325,000
| – | – | 0.31% | 80 |
|
|
2021
Q2 | $7.13M | Hold |
325,000
| – | – | 0.48% | 68 |
|
|
2021
Q1 | $7.82M | Buy |
325,000
+85,000
| +35% | +$2.05M | 0.55% | 55 |
|
|
2020
Q4 | $4.32M | Buy |
240,000
+50,000
| +26% | +$900K | 0.35% | 68 |
|
|
2020
Q3 | $2.2M | Hold |
190,000
| – | – | 0.2% | 75 |
|
|
2020
Q2 | $4.61M | Sell |
190,000
-60,172
| -24% | -$1.46M | 0.5% | 65 |
|
|
2020
Q1 | $2.76M | Sell |
250,172
-13,228
| -5% | -$146K | 0.39% | 68 |
|
|
2019
Q4 | $6.96M | Sell |
263,400
-272,257
| -51% | -$7.2M | 0.76% | 55 |
|
|
2019
Q3 | $12.2M | Buy |
535,657
+261,383
| +95% | +$5.95M | 1.53% | 26 |
|
|
2019
Q2 | $8.41M | Buy |
274,274
+62,105
| +29% | +$1.9M | 0.93% | 47 |
|
|
2019
Q1 | $3.52M | Buy |
212,169
+39,349
| +23% | +$653K | 0.41% | 63 |
|
|
2018
Q4 | $3.31M | Buy |
+172,820
| New | +$3.31M | 0.38% | 65 |
|